Huma is a medtech startup and it aims to transform healthcare and research globally. Its digital ‘hospital at home’ and decentralised clinical trial platform better enable patients, clinicians, researchers, and healthcare systems to keep tabs and be up to date on what’s happening. It uses real-time health data from smartphones in order to do so.
Huma has raised €181M across 2 funding rounds from 10 investors, most recently a Series D+ round in Jul 2024. Based in UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2024-07-16 | Series D+ | €73M | AstraZeneca,Hat Technology Fund,Hitachi Ventures,Leaps by Bayer | View deal → |
| 2021-05-12 | Series C | €107M | HAT Technology & Innovation Fund,Hitachi Ventures,Leaps by Bayer,Michael Diekmann,Nikesh Arora,Samsung Next+2 more | View deal → |
